Anabolicum Vister (Quinbolone)

Unfortunately, Anabolicum Vister (Quinbolone) wasn’t very popular worldwide, and most of the research on it was written in Italian. Anabolicum Vister is yet another attempt at creating a steroid with the basic idea of altering the Methandrostenolone/Boldenone structure. As we already know, Equipoise (Boldenone) is essentially a 17-alpha alkylated version of Dianabol, with the addition of an Undeclynate ester.

What we’re looking at in Anabolicum Vister (Quinbolone) is essentially Eq or Boldenone, but with a cyclopentenyl ester at the 17-alpha position to increase its lipophilicity, instead of the undeclynate ester found in Eq. It’s yet another attempt at a non-toxic oral anabolic like Andriol, and it used a similar delivery system.

It was sealed in an oil-filled capsule, so that the oil could be absorbed by the lymphatic system just like it is with Andriol and thus it could bypass the liver and avoid being broken down that way, which is how most oral steroids (the 17-alpha-alkylated ones) work.

Anyway, as you may have heard, using the lymphatic system as a delivery vehicle for steroids is very problematic. Blood levels are all over the place, and in some people, it seemed as if most of the time it didn’t metabolize properly at all. Therefore, as with Andriol, effective doses of this steroid are necessarily high.

Originally, each capsule had 10 mg of quinbolone, and you needed to take 10-20 capsules mg to get any kind of decent anabolic effect. While you won’t get any benefits with Anabolicum Vister over regular Eq, it will basically do all of the same things Eq will. This stuff will help you lose a bit of fat, will increase strength and muscle, and also (as Eq is noted for) increase red blood cell production. The kicker, for me, is that this drug was given a new name, Quinbolone, while it’s basically just boldenone cyclopentenyl.

Info and Reviews

Regrettably, Anabolicum Vister (Quinbolone) never gained much popularity in the United States, and most of the available research on it is in Italian. This language barrier can make it challenging for those uncomfortable with foreign texts.

Anabolicum Vister was another attempt at tweaking the structure of Methandrostenolone/Boldenone. Equipoise (Boldenone) is essentially a version of Dianabol without the 17alpha alkylation, combined with an Undeclynate ester. Anabolicum Vister (Quinbolone) sought to mimic Boldenone but with a cyclopentenyl ester at the 17-alpha position to increase lipophilicity instead of the undeclynate ester found in Boldenone. The goal was to create a non-toxic oral anabolic, similar to Andriol, using a comparable delivery method. Encased in oil-filled capsules like Andriol, it could be absorbed by the lymphatic system, avoiding hepatic breakdown, a common issue with oral steroids.

However, utilizing the lymphatic system for steroid delivery posed problems, resulting in inconsistent blood levels and inefficient metabolism in some users. Consequently, effective doses of Anabolicum Vister were often high. Originally, each capsule contained 10 mg of quinbolone, necessitating 10-20 capsules for noticeable anabolic effects. Despite its similarities to Equipoise, Anabolicum Vister offered no significant advantages. It aided in fat loss, boosted strength and muscle mass, and enhanced red blood cell production, typical traits associated with Equipoise.

Despite being rebranded as Quinbolone, essentially a cyclopentenyl derivative of boldenone, the drug’s naming seemed perplexing.

Similar to its base compound, Boldenone, Anabolicum Vister was considered relatively safe, lacking liver toxicity, and displaying minimal interaction with the 5AR enzyme. It also exhibited reduced aromatization, mitigating estrogen conversion compared to testosterone or Methandrostenolone (dbol).

While Anabolicum Vister has been discontinued by its original manufacturer, its potential as an oral alternative to Equipoise may still be explored, especially if produced by underground labs.

Its very good on the liver with low side effects

As we already know from the properties of Boldenone base, this is a particularly safe steroid. Anabolicum Vister is not liver toxic and has little or no interaction with the 5AR enzyme, so it doesn’t really form much more than the androgenic metabolite Dihydroboldenone. We also know that it has only half the ability to interact with aromatase as testosterone, so it won’t convert too much estrogen. Unlike its brother, Methandrostenolone (d-bol), it doesn’t have the structural alteration of the 17-alpha-methyl group that makes it form a more potent estrogen. What we have here (although it has been discontinued) is basically oral Eq, which requires too many capsules per day to be cost-effective compared to injectable Eq, but nonetheless may be an interesting drug if an underground lab starts producing some. The original company that made it has, sadly, stopped doing so.

• Manufacturer: Parke Davis (Discontinued)
• Effective Dose (women): 50-100mgs/day
• Active Life: less than 8-12 hours Detection Time:2-3 months
• Anabolic/Androgenic Ratio: 100:50
• Molecular Formula (of Base): C19H26O2
• Molecular Formula (of Ester):N/A
• Molecular Weight (of Base): 286.4132
• Molecular Weight (of Ester): 352.5156
• Melting Point:N/A Quinbolone [1,4-androstadiene-3-one,17b-ol (+ ester 17beta-(1-Cyclopenten-1-yloxy)]

References

1. [Controlled studies of the comparative effects of an anabolic steroid (quinbolone) and cobamamide on weight gain, skinfold thickness and secondary sex characters in a group of children of both sexes. Preliminary note] Minerva Pediatr. 1972 Jul 14; 24(25):1040-50. Italian.
2. [Human pharmacological study of quinbolone. Clinical and Laboratory investigations of the effects of anabolic treatment in aged women] G Gerontol. 1972 Apr; 20(4):361-78. Italian.
3. [Metabolism of 1-dehydroandrostanes in man. I. Metabolism of 17 -hydroxyandrosta-1, 4-dien-3-one, 17 -cyclopent-1′-enyloxyandrosta-1, 4-dien-3-one (quinbolone) and androsta-1,4-diene-3,17-dione (1)] Steroids. 1971 Jul; 18(1):39-50.
4. [The action of quinbolone on nitrogen metabolism in humans] G Clin Med. 1967 Jun;48(6):632-44. Italian.
5. [Considerations on the use of a new non 17-alpha-alkylated anabolic steroid, active orally: quinbolone. Study of liver function] Rass Fisiopatol Clin Ter. 1965 May-Jun;37(3):165-77.
6. [Clinical study of a new anabolic preparation: Quinbolone] Gazz Med Ital. 1965 Dec;124(12):360-6. Italian.
7. [Pituitary activity and quinbolone] Minerva Med. 1977 Jun 30;68(32):2245-8. Italian.
8. [Erythropoietic action of an oral non-17-alkylated anabolic steroid] Clin Ter. 1979 Nov 15;91(3):267-78. Italian.
9. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment] Clin Ter. 1980 Jul 15;94(1):57-65. Italian.